Stay updated on Pfizer Press Releases

Sign up to get notified when there's something new on the Pfizer Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Pfizer Press Releases page

  1. Check
    yesterday
    Change Detected
    Summary
    A new press release announces Pfizer’s exclusive licensing agreement with Starna Therapeutics for autoimmune diseases. The listing for Pfizer’s October 1, 2026, Phase 2 atopic dermatitis study of Tilrekimig is no longer present.
    Difference
    2%
    Check dated 2026-11-21T18:39:57.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The Pfizer newsroom page displays its press release archive, including dated headlines, category filters, and footer information.
    Difference
    100%
    Check dated 2026-11-14T19:19:38.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The press release archive adds announcements on Pfizer’s third-quarter 2026 results and raised guidance, as well as Cecile Guegan’s appointment as chief financial officer. A listing for a webcast about Pfizer’s participation in a healthcare conference is no longer shown.
    Difference
    36%
    Check dated 2026-11-08T00:57:05.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The press-release list now features October 2026 announcements about ELREXFIO’s Phase 3 results and TALZENNA plus XTANDI’s FDA approval. Older August 2026 releases about Pfizer’s Lyme disease vaccine candidate and the updated COVID-19 vaccine are no longer shown.
    Difference
    4%
    Check dated 2026-10-31T19:10:13.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The press-release listing now includes Pfizer’s report of robust Phase 2 results for its 25-valent pediatric pneumococcal vaccine candidate. It no longer lists the release reporting second-quarter results and updated 2026 revenue guidance.
    Difference
    0.9%
    Check dated 2026-10-24T22:26:59.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    A new October 14, 2026 press release highlights Pfizer’s clinical advancements across infectious diseases at IDWeek. The July 2026 LITFULO Phase 3 results announcement and its related listing labels are no longer shown.
    Difference
    1%
    Check dated 2026-10-17T22:23:19.000Z thumbnail image

Stay in the know with updates to Pfizer Press Releases

Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.